Cargando…
Perioperative Management of Dental Surgery Patients Chronically Taking Antithrombotic Medications
The development of medicine is based not only on the introduction of new methods of treatment, but also on the use of increasingly effective drugs, including antithrombotic drugs. Drugs that inhibit the activity of platelets (antiplatelet and anti-aggregating drugs) and pharmaceuticals that inhibit...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737598/ https://www.ncbi.nlm.nih.gov/pubmed/36498241 http://dx.doi.org/10.3390/ijerph192316151 |
_version_ | 1784847330477867008 |
---|---|
author | Wójcik, Sylwia Mocny-Pachońska, Katarzyna Bisch-Wójcik, Sophie Balicz, Agnieszka Morawiec, Tadeusz |
author_facet | Wójcik, Sylwia Mocny-Pachońska, Katarzyna Bisch-Wójcik, Sophie Balicz, Agnieszka Morawiec, Tadeusz |
author_sort | Wójcik, Sylwia |
collection | PubMed |
description | The development of medicine is based not only on the introduction of new methods of treatment, but also on the use of increasingly effective drugs, including antithrombotic drugs. Drugs that inhibit the activity of platelets (antiplatelet and anti-aggregating drugs) and pharmaceuticals that inhibit the activity of plasma coagulation factors (anticoagulants) are used in antithrombotic therapy. In our daily practice we encounter patients who take chronic antiplatelet or anticoagulant drugs. However, more and more often we are dealing with patients who are treated with two antiplatelet drugs, an antiplatelet and an anticoagulant or even undergoing triple antithrombotic therapy. When preparing the patient for invasive craniofacial procedures, it should be assessed whether the temporary discontinuation of antithrombotic treatment due to the fear of excessive perioperative bleeding is justified and will not result in life-threatening thromboembolic complications. The authors discuss in detail the medications used in modern antithrombotic treatment and present a perioperative management procedure with a patient who takes l4 z of these medications chronically. |
format | Online Article Text |
id | pubmed-9737598 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97375982022-12-11 Perioperative Management of Dental Surgery Patients Chronically Taking Antithrombotic Medications Wójcik, Sylwia Mocny-Pachońska, Katarzyna Bisch-Wójcik, Sophie Balicz, Agnieszka Morawiec, Tadeusz Int J Environ Res Public Health Review The development of medicine is based not only on the introduction of new methods of treatment, but also on the use of increasingly effective drugs, including antithrombotic drugs. Drugs that inhibit the activity of platelets (antiplatelet and anti-aggregating drugs) and pharmaceuticals that inhibit the activity of plasma coagulation factors (anticoagulants) are used in antithrombotic therapy. In our daily practice we encounter patients who take chronic antiplatelet or anticoagulant drugs. However, more and more often we are dealing with patients who are treated with two antiplatelet drugs, an antiplatelet and an anticoagulant or even undergoing triple antithrombotic therapy. When preparing the patient for invasive craniofacial procedures, it should be assessed whether the temporary discontinuation of antithrombotic treatment due to the fear of excessive perioperative bleeding is justified and will not result in life-threatening thromboembolic complications. The authors discuss in detail the medications used in modern antithrombotic treatment and present a perioperative management procedure with a patient who takes l4 z of these medications chronically. MDPI 2022-12-02 /pmc/articles/PMC9737598/ /pubmed/36498241 http://dx.doi.org/10.3390/ijerph192316151 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Wójcik, Sylwia Mocny-Pachońska, Katarzyna Bisch-Wójcik, Sophie Balicz, Agnieszka Morawiec, Tadeusz Perioperative Management of Dental Surgery Patients Chronically Taking Antithrombotic Medications |
title | Perioperative Management of Dental Surgery Patients Chronically Taking Antithrombotic Medications |
title_full | Perioperative Management of Dental Surgery Patients Chronically Taking Antithrombotic Medications |
title_fullStr | Perioperative Management of Dental Surgery Patients Chronically Taking Antithrombotic Medications |
title_full_unstemmed | Perioperative Management of Dental Surgery Patients Chronically Taking Antithrombotic Medications |
title_short | Perioperative Management of Dental Surgery Patients Chronically Taking Antithrombotic Medications |
title_sort | perioperative management of dental surgery patients chronically taking antithrombotic medications |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737598/ https://www.ncbi.nlm.nih.gov/pubmed/36498241 http://dx.doi.org/10.3390/ijerph192316151 |
work_keys_str_mv | AT wojciksylwia perioperativemanagementofdentalsurgerypatientschronicallytakingantithromboticmedications AT mocnypachonskakatarzyna perioperativemanagementofdentalsurgerypatientschronicallytakingantithromboticmedications AT bischwojciksophie perioperativemanagementofdentalsurgerypatientschronicallytakingantithromboticmedications AT baliczagnieszka perioperativemanagementofdentalsurgerypatientschronicallytakingantithromboticmedications AT morawiectadeusz perioperativemanagementofdentalsurgerypatientschronicallytakingantithromboticmedications |